New US FDA Biologics License Pathway Could Be Missing Link To Reduce Animal Testing

 
• By Bridget Silverman
  
A new US FDA regulatory pathway for biologics could simplify efforts to reduce reliance on animal testing (Shutterstock)

More from R&D

More from Advanced Technologies